|

Invivo CAR-T Clinical Trials

2 actively recruiting trials

▲ +1 trial since July 2026

Pipeline

Phase 1: 2

Top Sponsors

  • Chongqing Precision Biotech Co., Ltd2

Indications

  • Cancer2
  • B-cell Non-Hodgkin's Lymphoma1
  • Relapsed or Refractory Multiple Myeloma (RRMM)1
  • B Acute Lymphoblastic Leukemia1
  • Multiple Myeloma1

Other2 trials

In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
Phase 1
In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.